Safety and Efficacy of CMX-2043 for Protection of the Heart and Kidneys in Subjects Undergoing Coronary Angiography
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 361 participants.
Also called NCT02103959
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 361 participants
- Sponsor
- Ischemix, LLC
- Registry
-
NCT02103959
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT02103959. Randomized; quadruple masking; primary purpose prevention. Start 2014-06 (registry gives no type); primary completion 2015-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of CMX-2043 for Protection of the Heart and Kidneys in Subjects Undergoing Coronary Angiography
- Acronym
- CARIN
- Condition
- Non STEMI
- Condition
- Unstable Angina
- Intervention (Drug)
- CMX-2043
- Intervention (Drug)
- Placebo comparator
- Lead sponsor
- Ischemix, LLC
Record details
- Record id
cardio:ct-nct02103959- Content hash
aa064529ab8421c526658a2f079391830b8315ad7b451b8879f96cbe36fe11c0